Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 6 clinical trials
Clinical Study of Kangfuxin and Basic Fibroblast Growth Factor in Promoting the Healing of Donor Site

The main objective of this study is to observe whether basic fibroblast growth factor and Kangfuxin Liquid can promote the wound healing in the donor area and further evaluate the healing

Accepts healthy volunteers
  • 0 views
  • 24 Feb, 2022
  • 1 location
Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study (CABATEN)

growth factor (VEGF), platelet-derived growth factor (PDGF), insulin-like growth factor 1 (IGF-1), basic fibroblast growth factor (BFGF), and transforming growth factor (TGF)-α and -β. The (over

neuroendocrine carcinoma
adrenal pheochromocytoma
radionuclide therapy
adrenaline
lung cancer
  • 0 views
  • 24 Mar, 2022
  • 14 locations
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

This is a phase 1, multicenter, open-label study evaluating the safety and efficacy of ruxolitinib, steroids and lenalidomide among MM patients who currently show progressive disease.

refractory multiple myeloma
monoclonal antibodies
monoclonal protein
electrophoresis
vasectomy
  • 36 views
  • 29 Apr, 2022
  • 8 locations
Cytokine Change in Hepatocellular Carcinoma Treated by Thermal Ablation

Background: Hepatocellular carcinoma (HCC) is the most common primary liver cancer with aggressive tumor behavior. Radiofrequency ablation (RFA) or microwave ablation (MWA) is an effective curative treatment for early stage HCC. This thermal ablation of liver tumor induces host immune response with changes in serum concentration of various cytokines. It …

renal function
cancer
metastasis
  • 2 views
  • 11 Mar, 2022
  • 1 location
Aflibercept or Bevacizumab as Second-line Treatment of RAS Mutated Metastatic Colorectal Cancer

(VEGF-A and C), stromal cell-derived factor-1 (SDF-1), platelet-derived growth factor beta (PDGF-), basic fibroblast growth factor (bFGF), interleukin-8 (IL-8), chemokine (C-C motif) ligand 2 (CCL2

vegf
fluoropyrimidine
oxaliplatin
folfiri regimen
EGFR
  • 0 views
  • 24 Jan, 2021
  • 1 location
Derivation of New Human Embryonic Stem Cell Lines Lines for Clinical Use

Human embryonic stem cells (hESCs) are isolated from the early human embryo and have the capability to proliferate indefinitely in culture and to develop into nearly every cell of the human body. Therefore, hESCs may serve as a renewable unlimited source of cells for transplantation therapy. Because of the use …

Accepts healthy volunteers
blood test
  • 129 views
  • 04 Oct, 2022
  • 1 location